Retatrutide is a cutting-edge investigational peptide currently being studied for its potential multi-receptor agonist activity, specifically targeting the GLP-1, GIP, and glucagon receptors. This 10mg vial of Retatrutide is offered as a high-purity, lyophilized peptide designed strictly for scientific and laboratory research.